15 years closing six and seven-figure deals in healthcare supply chain and life sciences. Now bringing that track record to the companies shaping AI.
For 15 years, I've watched the industry with the highest stakes move slower than almost any other on technology adoption. The reasons aren't hard to understand: regulation, risk aversion, genuine fear of getting it wrong. But staying put has costs too. AI is the first thing I've seen that can actually shift that.
I've spent my career selling platforms where massive data flows meet operations that can't afford to fail. The companies building AI for the enterprise need sellers who know that territory. People who can walk into a room of skeptical VPs and make the abstract feel inevitable.
I'm already operating this way. I use AI to run tailored outreach at scale, build executive-ready presentations faster than my competitors expect, and find the right opportunities before they know they exist. This isn't where I'm headed. It's how I already work.
For 15 years, the ROI conversation in healthcare was about cost and friction. AI — built responsibly — is the first technology where it can genuinely be about outcomes: a drug that reaches patients faster, a diagnosis that doesn't get missed, access to care that didn't exist before. That's what I want to spend the next chapter selling.
The team bringing AI into healthcare and life sciences needs someone who already speaks the language. I've spent the last decade in that room. Let's talk about what that looks like on your team.